APA (7th ed.) Citation

Demidova, T. Y., Krasil’nikova, E. I., Vorob’ev, S. V., Morugova, T. V., & Adasheva, T. V. (2021). The use of drug based on technologically processed antibodies to endocannabinoid receptor type 1 in the treatment of obesity in adults: Results of a multicenter double blind placebo controlled randomized clinical trial. "Consilium Medicum" Publishing house.

Chicago Style (17th ed.) Citation

Demidova, Tatiana Y., Elena I. Krasil’nikova, Sergey V. Vorob’ev, Tatiana V. Morugova, and Tatiana V. Adasheva. The Use of Drug Based on Technologically Processed Antibodies to Endocannabinoid Receptor Type 1 in the Treatment of Obesity in Adults: Results of a Multicenter Double Blind Placebo Controlled Randomized Clinical Trial. "Consilium Medicum" Publishing house, 2021.

MLA (8th ed.) Citation

Demidova, Tatiana Y., et al. The Use of Drug Based on Technologically Processed Antibodies to Endocannabinoid Receptor Type 1 in the Treatment of Obesity in Adults: Results of a Multicenter Double Blind Placebo Controlled Randomized Clinical Trial. "Consilium Medicum" Publishing house, 2021.